Colorado settles with two drug companies for $49 million in antitrust lawsuits
Colorado will settle antitrust claims against two pharmaceutical companies for nearly $50 million as part of ongoing lawsuits that allege some of the country’s largest generic prescription drug producers conspired to raise prices and reduce competition.
Attorney General Phil Weiser announced the $10 million settlement with Heritage Pharmaceuticals and $39.1 million settlement with Apotex on Thursday.
Colorado joined three multistate lawsuits against dozens of companies and executives between 2016 and 2020. The lawsuits claimed manufacturers such as Pfizer and Teva Pharmaceuticals “embarked on one of the most egregious and damaging price-fixing conspiracies in the history of the United States.”
